Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium

Journal of the American College of Cardiology

Volumn 44, Issue 3, 2004, Pages 654-660

  Christman, Karen L ^a   Vardanian, Andrew J ^b   Fang, Qizhi ^a   Sievers, Richard E ^b   Fok, Hubert H ^b   Lee, Randall J ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Cardiac Electrophysiology   (United States)

Author keywords

4 ,6 diamidino 2 phenylindole; bovine serum albumin; BSA; DAPI; left ventricle; LV; MHC; MI; myocardial infarction; myosin heavy chain; PBS; phosphate buffered saline

Indexed keywords

FIBRIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CELL SURVIVAL; CELL TRANSPLANTATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LEFT CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; DISEASE MODELS, ANIMAL; FEMALE; FIBRIN TISSUE ADHESIVE; GRAFT SURVIVAL; HEART VENTRICLES; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRALESIONAL; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; TISSUE ADHESIVES; TRANSPLANTATION, AUTOLOGOUS;

EID: 4143129956     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.04.040     Document Type: Article

References (38)

1. Ghostine S., Carrion C., Souza L.C., et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation. 106:2002;I131-I136
2. Gojo S., Kitamura S., Hatano O., et al. Transplantation of genetically marked cardiac muscle cells. J Thorac Cardiovasc Surg. 113:1997;10-18
3. Jain M., DerSimonian H., Brenner D.A., et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation. 103:2001;1920-1927
4. Li R.K., Jia Z.Q., Weisel R.D., et al. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg. 62:1996;654-660
5. Muller-Ehmsen J., Whittaker P., Kloner R.A., et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol. 34:2002;107-116
6. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature. 410:2001;701-705
7. Reinecke H., Zhang M., Bartosek T., Murry C.E. Survival, integration, and differentiation of cardiomyocyte grafts A study in normal and injured rat hearts. Circulation. 100:1999;193-202
8. Reinecke H., Murry C.E. Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing? Cardiovasc Pathol. 9:2000;337-344
9. Sakai T., Li R.K., Weisel R.D., et al. Fetal cell transplantation A comparison of three cell types. J Thorac Cardiovasc Surg. 118:1999;715-724
10. Scorsin M., Hagege A.A., Marotte F., et al. Does transplantation of cardiomyocytes improve function of infarcted myocardium? Circulation. 96:1997;II-188-II-193
11. Zhang M., Methot D., Poppa V., Fujio Y., Walsh K., Murry C.E. Cardiomyocyte grafting for cardiac repair Graft cell death and anti-death strategies. J Mol Cell Cardiol. 33:2001;907-921
12. Reinecke H., Murry C.E. Taking the death toll after cardiomyocyte grafting A reminder of the importance of quantitative biology. J Mol Cell Cardiol. 34:2002;251-253
13. Leor J., Aboulafia-Etzion S., Dar A., et al. Bioengineered cardiac grafts A new approach to repair the infarcted myocardium? Circulation. 102:2000;III56-III61
14. Kellar R.S., Landeen L.K., Shepherd B.R., Naughton G.K., Ratcliffe A., Williams S.K. Scaffold-based three-dimensional human fibroblast culture provides a structural matrix that supports angiogenesis in infarcted heart tissue. Circulation. 104:2001;2063-2068
15. Thompson W.D., Smith E.B., Stirk C.M., Marshall F.I., Stout A.J., Kocchar A. Angiogenic activity of fibrin degradation products is located in fibrin fragment E. J Pathol. 168:1992;47-53
16. Bootle-Wilbraham C.A., Tazzyman S., Thompson W.D., Stirk C.M., Lewis C.E. Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro. Angiogenesis. 4:2001;269-275
17. Naito M., Stirk C.M., Smith E.B., Thompson W.D. Smooth muscle cell outgrowth stimulated by fibrin degradation products. The potential role of fibrin fragment E in restenosis and atherogenesis. Thromb Res. 98:2000;165-174
18. Dvorak H.F., Harvey V.S., Estrella P., Brown L.F., McDonagh J., Dvorak A.M. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest. 57:1987;673-686
19. Christman K., Fok H.H., Sievers R.E., Fang Q., Lee R.J. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 10:2004;403-409
20. Sievers R.E., Schmiedl U., Wolfe C.L., et al. A model of acute regional myocardial ischemia and reperfusion in the rat. Magn Reson Med. 10:1989;172-181
21. Wolfe C.L., Moseley M.E., Wikstrom M.G., et al. Assessment of myocardial salvage after ischemia and reperfusion using magnetic resonance imaging and spectroscopy. Circulation. 80:1989;969-982
22. Zhu B., Sun Y., Sievers R.E., et al. Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion. J Am Coll Cardiol. 35:2000;787-795
23. Zhu B., Sun Y., Sievers R.E., et al. Effects of different durations of pretreatment with losartan on myocardial infarct size, endothelial function, and vascular endothelial growth factor. J Renin Angiotensin Aldosterone Syst. 2:2001;129-133
24. Rando T.A., Blau H.M. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol. 125:1994;1275-1287
25. Fishbein M.C., Maclean D., Maroko P.R. Experimental myocardial infarction in the rat Qualitative and quantitative changes during pathologic evolution. Am J Pathol. 90:1978;57-70
26. Kloner R.A., Dow J., Chung G., Kedes L.H. Intramyocardial injection of DNA encoding vascular endothelial growth factor in a myocardial infarction model. J Thromb Thrombolysis. 10:2000;285-289
27. Li W., Tanaka K., Chiba Y., et al. Role of MMPs and plasminogen activators in angiogenesis after transmyocardial laser revascularization in dogs. Am J Physiol Heart Circ Physiol. 284:2003;H23-H30
28. Havenith M.G., Visser R., Schrijvers-van Schendel J.M., Bosman F.T. Muscle fiber typing in routinely processed skeletal muscle with monoclonal antibodies. Histochemistry. 93:1990;497-499
29. Tambara K., Sakakibara Y., Sakaguchi G., et al. Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation. 108:(Suppl 1):2003;II259-II263
30. Sierra D.H. Fibrin sealant adhesive systems A review of their chemistry, material properties and clinical applications. J Biomater Appl. 7:1993;309-352
31. Seelich T. Biochemistry and methods of application. J Head Neck Pathol 1982;365-9.
32. Benjamin L.E., Hemo I., Keshet E. A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development. 125:1998;1591-1598
33. Thiagarajan P., Rippon A.J., Farrell D.H. Alternative adhesion sites in human fibrinogen for vascular endothelial cells. Biochemistry. 35:1996;4169-4175
34. Vailhe B., Ronot X., Tracqui P., Usson Y., Tranqui L. In vitro angiogenesis is modulated by the mechanical properties of fibrin gels and is related to alpha(v)beta3 integrin localization. In Vitro Cell Dev Biol Anim. 33:1997;763-773
35. Bach T.L., Barsigian C., Chalupowicz D.G., et al. VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Exp Cell Res. 238:1998;324-334
36. Sahni A., Odrljin T., Francis C.W. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem. 273:1998;7554-7559
37. Harrison P., Cramer E.M. Platelet alpha-granules. Blood Rev. 7:1993;52-62
38. Radosevich M., Goubran H.I., Burnouf T. Fibrin sealant Scientific rationale, production methods, properties, and current clinical use. Vox Sang. 72:1997;133-143